This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Current Discounted Rates End In:

  • 00
  • 00
  • 00
  • 00
Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Philipp Wenter, Ph.D.
Senior Director of Drug Substance Manufacturing, Technical Operations at Apellis Pharmaceuticals

Agenda Sessions

  • Pegcetacoplan – Towards the Implementation of an Efficient Manufacturing Process for a PEG-ylated Peptide at an Industrial Scale, and the Associated Strategy for a Regulatory Approval